NEUROTOXICITY OF MEPERIDINE

被引：41

作者：

GOETTING, MG

THIRMAN, MJ

机构：

来源：

ANNALS OF EMERGENCY MEDICINE | 1985年 / 14卷 / 10期

关键词：

D O I：

10.1016/S0196-0644(85)80251-1

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1007 / 1009

页数：3

共 14 条

[1]

Andrews HL, 1942, J PHARMACOL EXP THER, V76, P89

[2] CLASSIFICATION OF OPIOIDS ON THE BASIS OF CHANGE IN SEIZURE THRESHOLD IN RATS [J].

COWAN, A ;

GELLER, EB ;

ADLER, MW .

SCIENCE, 1979, 206 (4417) :465-467

[3]

DENEAU GA, 1961, B DRUG ADDICTION NAR, V6, P2460

[4] MEPERIDINE-ASSOCIATED MYOCLONUS AND SEIZURES IN LONG-TERM HEMODIALYSIS-PATIENTS [J].

HOCHMAN, MS .

ANNALS OF NEUROLOGY, 1983, 14 (05) :593-593

[5] CENTRAL NERVOUS-SYSTEM EXCITATORY EFFECTS OF MEPERIDINE IN CANCER-PATIENTS [J].

KAIKO, RF ;

FOLEY, KM ;

GRABINSKI, PY ;

HEIDRICH, G ;

ROGERS, AG ;

INTURRISI, CE ;

REIDENBERG, MM .

ANNALS OF NEUROLOGY, 1983, 13 (02) :180-185

[6]

MATHER LE, 1976, CLIN PHARMACOL THER, V20, P535

[7]

MILLER JW, 1954, J PHARMACOL EXP THER, V112, P191

[8]

PLOTNIKOFF NP, 1956, J PHARMACOL EXP THER, V117, P414

[9] EFFECT OF PHENYTOIN ON MEPERIDINE CLEARANCE AND NORMEPERIDINE FORMATION [J].

POND, SM ;

KRETSCHZMAR, KM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :680-686

[10] CLINICAL PHARMACOLOGY OF MEPERIDINE - COMPARISON OF ROUTES OF ADMINISTRATION [J].

STAMBAUGH, JE ;

WAINER, IW ;

SANSTEAD, JK ;

HEMPHILL, DM .

JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (5-6) :245-256

← 1 2 →